Envoy Medical COCH Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $241K+7.1% | $225K-28.8% | $316K— | —— | ||
| $874K+17.8% | $742K-2.4% | $760K— | —— | ||
| -$633K-22.4% | -$517K-16.4% | -$444K— | —— | ||
| -262.7%-32.9pp | -229.8%-89.3pp | -140.5%— | —— | ||
| $12.49M+22.7% | $10.18M+13.3% | $8.99M— | —— | ||
| $1.22M-29.6% | $1.73M+4.1% | $1.67M+88.2% | $885K— | ||
| $7.93M+16.2% | $6.83M-6.0% | $7.26M— | —— | ||
| $22.51M+15.5% | $19.48M+4.3% | $18.68M+160% | $7.17M+19.7% | ||
| -$22.27M-15.6% | -$19.26M-4.9% | -$18.36M-159% | -$7.09M-18.4% | ||
| -9,240.7%-682pp | -8,558.7%-2,749pp | -5,809.8%— | —— | ||
| $1.59M+94.9% | $816K— | —— | —— | ||
| -$1.49M+3.4% | -$1.54M— | —— | —— | ||
| -$23.76M-14.2% | -$20.8M+30.5% | -$29.92M-87.9% | -$15.92M-6,228% | ||
| -9,857.3%-615pp | -9,242.2%+227pp | -9,469%— | —— | ||
| -$1.22+18.1% | -$1.49+42.0% | -$2.57-165% | -$0.97-2,325% | ||
| -$21.97M-15.1% | -$19.08M-4.7% | -$18.23M— | —— | ||
| -9,115.4%-634pp | -8,481.8%-2,714pp | -5,767.7%— | —— | ||
| -$22.27M-15.6% | -$19.26M-4.9% | -$18.36M-159% | -$7.09M-18.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Envoy Medical's revenue?
- Envoy Medical (COCH) generated $234.0K in revenue over the trailing twelve months, up 10.4% year over year.
- Is Envoy Medical profitable?
- Envoy Medical is not currently profitable: it reported a net loss of $23.1M over the trailing twelve months, a -9875.6% net margin.
- What are Envoy Medical's profit margins?
- Gross margin is -310.7% and operating margin is -9881.2%, with a -9875.6% net margin.
- What is Envoy Medical's earnings per share?
- Envoy Medical's diluted EPS over the trailing twelve months is $-1.01.
- Where does Envoy Medical's income statement data come from?
- Every line is extracted from Envoy Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
